ARCHIVES

Recombinant TSH Avoids Need To Stop Replacement Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 1 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI extends Deadline for Three RFAs

July 9, 1999

Small Business Technology Transfer Program Solicitation

June 23, 1995

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977

Patient Advocacy: Prostate Cancer Agenda Didn’t Include NCI Plans, Lausner Says

November 29, 1996

In Brief: Upton Not Planning To Leave NCI, As Hinted By Califano, Over New Ethics Regulations

March 30, 1979

Low-Dose IFN Not Effective Against Melanoma, Study Finds

December 26, 2003